Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Modification in Patients With COVID-19 Under Early Intervention Treatment at U.M.F 13 and U.M.F 20

NCT04673214 is registered in ClinicalTrials.gov with Gilberto Cruz Arteaga as lead sponsor.

NCT NCT04673214
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04673214 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Modification in Patients With COVID-19 Under Early Intervention Treatment at U.M.F 13 and U.M.F 20
Lead sponsor
Gilberto Cruz Arteaga
Phase
Phase 3
Overall status
Completed
Start date
December 16, 2020
Completion date
February 25, 2021
Enrollment
114 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19